Takeda is finally on the up-and-up after posting growth in its last fiscal year. And to help keep that growth coming, it’s exploring an asset sale to drum up…

Mylan and Biocon said the European Medicines Agency has accepted an application for review for marketing authorization of a biosimilar of pegfilgrastim.

India may take a long-expected step this year and introduce a separate law on medical devices that fits in with the manufacturing aims of the government.

South Africa's Aspen Pharmacare has set its sights on rapid expansion in China.

Sales of Roche’s cancer drugs remain strong, giving the Swiss drugmaker a solid push in the first half of the year. And while execs acknowledge that a swarm of…

Pharma marketers may have felt reprieved after a former Warner Chilcott sales chief was acquitted last month. But now, two former Johnson & Johnson execs…

Industry groups have raised concerns after India has finally decided to place caps on the prices of at least two categories of heart stents.

Biogen CEO George Scangos is going out on an up note. The biotech, which today reported street-beating Q2 results, said he is stepping down as soon as a…

AstraZeneca’s ZS-9 setback last month did Relypsa a favor: It handed Veltassa sole control of the hyperkalemia market. That didn't hurt Relypsa’s chances…